Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Blair Medical Associates, Inc., Station Medical Center, Associates Wound Clinic
mi
from 91732
Altoona, PA
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Blair Medical Associates, Inc., Station Medical Center, Associates Wound Clinic
mi
from 91732
Altoona, PA
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Peripheral Vascular Associates
1189
mi
from 91732
San Antonio, TX
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Peripheral Vascular Associates
1189
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Dixie Regional Medical Center, Wound Care
mi
from 91732
Saint George, UT
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Dixie Regional Medical Center, Wound Care
mi
from 91732
Saint George, UT
Click here to add this to my saved trials
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
2562
mi
from 91732
Providence, RI
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Heart Rate Response to Regadenoson and Sudden Cardiac Death
Heart Rate Response to Regadenoson and Sudden Cardiac Death
Status: Enrolling
Updated:  12/31/1969
UAB
1785
mi
from 91732
Birmingham, AL
Heart Rate Response to Regadenoson and Sudden Cardiac Death
Heart Rate Response to Regadenoson and Sudden Cardiac Death
Status: Enrolling
Updated: 12/31/1969
UAB
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Cardiac Rehab for Advanced Heart Failure-LVAD Candidates
A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients Undergoing Evaluation for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
1524
mi
from 91732
Rochester, MN
Cardiac Rehab for Advanced Heart Failure-LVAD Candidates
A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients Undergoing Evaluation for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Study of the Sudden Heart Failure Participant Population in the US
Characterizing the Acute Decompensated Heart Failure (ADHF) Patient Population in the United States (US)
Status: Enrolling
Updated:  12/31/1969
Bristol-Myers Squibb
2398
mi
from 91732
Princeton, NJ
Study of the Sudden Heart Failure Participant Population in the US
Characterizing the Acute Decompensated Heart Failure (ADHF) Patient Population in the United States (US)
Status: Enrolling
Updated: 12/31/1969
Bristol-Myers Squibb
2398
mi
from 91732
Princeton, NJ
Click here to add this to my saved trials
Study of the Sudden Heart Failure Participant Population in the US
Characterizing the Acute Decompensated Heart Failure (ADHF) Patient Population in the United States (US)
Status: Enrolling
Updated:  12/31/1969
Local Institution
2399
mi
from 91732
Princeton, NJ
Study of the Sudden Heart Failure Participant Population in the US
Characterizing the Acute Decompensated Heart Failure (ADHF) Patient Population in the United States (US)
Status: Enrolling
Updated: 12/31/1969
Local Institution
2399
mi
from 91732
Princeton, NJ
Click here to add this to my saved trials
Pulse Oximeter Test
Accuracy of Pulse Oximeters With Profound Hypoxia
Status: Enrolling
Updated:  12/31/1969
UCSF Hypoxia Lab
41
mi
from 91732
San Francisco, CA
Pulse Oximeter Test
Accuracy of Pulse Oximeters With Profound Hypoxia
Status: Enrolling
Updated: 12/31/1969
UCSF Hypoxia Lab
41
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
Predicting and Monitoring Motor Development of Children Requiring Surgery as Neonates for Complex Congenital Heart Disease
Status: Enrolling
Updated:  12/31/1969
Advocate Children's Hospital
1722
mi
from 91732
Oak Lawn, IL
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
Predicting and Monitoring Motor Development of Children Requiring Surgery as Neonates for Complex Congenital Heart Disease
Status: Enrolling
Updated: 12/31/1969
Advocate Children's Hospital
1722
mi
from 91732
Oak Lawn, IL
Click here to add this to my saved trials
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment
Status: Enrolling
Updated:  12/31/1969
Albany Medical Center Neonatal Intesive Care Unit
2440
mi
from 91732
Albany, NY
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment
Status: Enrolling
Updated: 12/31/1969
Albany Medical Center Neonatal Intesive Care Unit
2440
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
1871
mi
from 91732
Birmingham, AL
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
1871
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
2136
mi
from 91732
Tampa, FL
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Winship Cancer Institute at Emory University
1922
mi
from 91732
Atlanta, GA
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Winship Cancer Institute at Emory University
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2302
mi
from 91732
Baltimore, MD
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Josephine Ford Cancer Center at Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Josephine Ford Cancer Center at Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Comprehensive Cancer Center
2124
mi
from 91732
Winston-Salem, NC
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Comprehensive Cancer Center
2124
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Taussig Cancer Center
2033
mi
from 91732
Cleveland, OH
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Taussig Cancer Center
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
Once Daily Enoxaparin for Outpatient Treatment of Acute Deep Venous Thrombosis and/or Pulmonary Embolism
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
Once Daily Enoxaparin for Outpatient Treatment of Acute Deep Venous Thrombosis and/or Pulmonary Embolism
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction
Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction
Status: Enrolling
Updated:  12/31/1969
Mercy Health Youngstown
2085
mi
from 91732
Youngstown, OH
Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction
Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction
Status: Enrolling
Updated: 12/31/1969
Mercy Health Youngstown
2085
mi
from 91732
Youngstown, OH
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
356
mi
from 91732
Chandler, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
356
mi
from 91732
Chandler, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
363
mi
from 91732
Gilbert, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
363
mi
from 91732
Gilbert, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
358
mi
from 91732
Mesa, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
358
mi
from 91732
Mesa, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
352
mi
from 91732
Scottsdale, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
352
mi
from 91732
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
353
mi
from 91732
Tempe, AZ
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
353
mi
from 91732
Tempe, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
16
mi
from 91732
Anaheim, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
16
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
28
mi
from 91732
Corona, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
28
mi
from 91732
Corona, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
21
mi
from 91732
Garden Grove, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
21
mi
from 91732
Garden Grove, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
28
mi
from 91732
Huntington Beach, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
28
mi
from 91732
Huntington Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
12
mi
from 91732
Norwalk, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
12
mi
from 91732
Norwalk, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
25
mi
from 91732
Tustin, CA
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
25
mi
from 91732
Tustin, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
814
mi
from 91732
Arvada, CO
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
814
mi
from 91732
Arvada, CO
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
825
mi
from 91732
Aurora, CO
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
817
mi
from 91732
Denver, CO
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
807
mi
from 91732
Golden, CO
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
807
mi
from 91732
Golden, CO
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
813
mi
from 91732
Littleton, CO
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
813
mi
from 91732
Littleton, CO
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2319
mi
from 91732
Aventura, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2319
mi
from 91732
Aventura, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2312
mi
from 91732
Deerfield Beach, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2312
mi
from 91732
Deerfield Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2304
mi
from 91732
Delray Beach, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2304
mi
from 91732
Delray Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2315
mi
from 91732
Hollywood, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2315
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2187
mi
from 91732
Kissimmee, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2187
mi
from 91732
Kissimmee, FL
Click here to add this to my saved trials
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2239
mi
from 91732
Melbourne, FL
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2239
mi
from 91732
Melbourne, FL
Click here to add this to my saved trials